PROMETRIKA, LLC’s Post

Recent insights from the Duke-Margolis Institute for Health Policy conference on clinical trial regulatory change highlights critical issues like integrating trials with community healthcare needs, balancing innovation with FDA standards, and modernizing regulatory frameworks.     There is emphasis on community-centric trials resonates deeply, advocating for inclusivity and practicality in research. Industry experts throughout the conference highlighted the necessity of balancing innovation with regulatory compliance, urging for transparent communication and change management. These insights underscore the imperative for adaptable, equitable clinical research methodologies in today's healthcare landscape.    Read the article by Moe Alsumidaie from The Clinical Trial Vanguard: https://bit.ly/3TQJTpn   #clinicaltrials #regulatorychange #healthcareinnovation 

Have you ever wondered why some medical treatments don’t seem to work? Our free webinar, “Why and How FDA Approval Standards for Drugs and Devices Don’t Always Make Sense” will give you the information you need to make informed medical decisions. The webinar is next week and is sponsored by the Patient Safety Action Network, and features NCHR's president, Dr. Diana Zuckerman. Gain insights into the nuances of drug and device approvals. Join us Wednesday, Feb 21, from 2-3 pm EST. Learn more and register at the link here:  https://lnkd.in/e4fjCTZF #FDAStandards #HealthPolicy #Webinar

If the proposed IRBs: Cooperative Research rule is approved, a single IRB will be required for multi-site clinical trials within the U.S. – reducing administrative burden for study teams and IRBs, allowing for faster trial start-up, and protecting patient safety. Let’s take a closer look at the possible real-world impact which could be beneficial to all key trial stakeholders. https://bit.ly/3NsY55E #drugdevelopment #clinicaltrials

Diversity & clinical trials: - Participants from different backgrounds. - A more realistic picture of the society. - Trials’ results will be more applicable to diverse populations. #clinicalresearch #clinicaltrials #regulatoryaffairs #medicalwriting

🌏 Exploring the Benefits of Conducting Clinical Trials in Asia-Pacific Regions 🏥 Considering conducting clinical trials? Discover why Asia-Pacific regions are the optimal choice! From diverse patient populations to streamlined regulatory processes, Asia-Pacific offers unparalleled advantages for advancing medical research. Learn more in our latest article! #ClinicalTrials #AsiaPacific #MedicalResearch 👉 Contact @Credevo for conducting your clinical trials in the Asia-Pacific region! https://buff.ly/3Va5viT

I recently watched a webinar from the FDA on how we can better design decentralized clinical trials (DCTs) to ensure they’re just as, if not more, effective than traditional ones. As work-from-home remains commonplace since the pandemic, it’s great to see the FDA adapting to make clinical trials more accessible. DCTs, like any clinical trial, must have effective parameters to ensure and measure their impact, but they’re a tremendous tool to help get therapies to the customers who need them faster. https://lnkd.in/g_eH6Zv9

Diversity & clinical trials: - Participants from different backgrounds. - A more realistic picture of the society. - Findings will be more applicable to diverse populations. #clinicalresearch #clinicaltrials #regulatoryaffairs #medicalwriting

If the proposed IRBs: Cooperative Research rule is approved, a single IRB will be required for multi-site clinical trials within the U.S. – reducing administrative burden for study teams and IRBs, allowing for faster trial start-up, and protecting patient safety. Let’s take a closer look at the possible real-world impact which could be beneficial to all key trial stakeholders. https://bit.ly/3SxFmJm #clinicaltrials #patientsafety

Intesting read. Provide perspective of expectations - future of clinical trials.

🌏 Exploring the Benefits of Conducting Clinical Trials in Asia-Pacific Regions 🏥 Considering conducting clinical trials? Discover why Asia-Pacific regions are the optimal choice! From diverse patient populations to streamlined regulatory processes, Asia-Pacific offers unparalleled advantages for advancing medical research. Learn more in our latest article! #ClinicalTrials #AsiaPacific #MedicalResearch 👉 Contact @Credevo for conducting your clinical trials in the Asia-Pacific region! https://buff.ly/4akkSt9